| 摘要 |
The present invention relates to (-)-1-(3,4-dichlorophenyl)-3- azabicyclo[3.1.0]hexane and pharmaceutically acceptable salts thereof, compositions comprising (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane or a pharmaceutically acceptable salt thereof, and methods for treating or preventing a disorder alleviated by inhibiting dopamine reuptake. In one embodiment, the disorder is attention-deficit disorder, depression, obesity, Parkinson's disease, a tic disorder, or an addictive disorder. The (-)-1-(3, 4- dichlorophenyl)-3-azabicyclo[3.1.0]hexane or pharmaceutically acceptable sal t thereof is preferably substantially free of its corresponding (+)-enantiomer .
|
